Nordström et al [10] also demonstrated that integration of Stockholm3 and MRI improved the sensitivity of the test compared with the original study and, by increasing the Stockholm3 threshold to 15, achieved similar sensitivity to PSA ≥ 3 ng/ml for detecting clinically significant prostate cancer. This evidence concerns the gene KLK3 and prostate carcinoma.